Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Immatics US, Inc.
Genmab
Bristol-Myers Squibb
Suzhou BlueHorse Therapeutics Co., Ltd.
Neonc Technologies, Inc.
Tesaro, Inc.
Toray Industries, Inc
Iovance Biotherapeutics, Inc.
M.D. Anderson Cancer Center
Shanghai Junshi Bioscience Co., Ltd.
DEKA Biosciences
Seagen Inc.
Eli Lilly and Company
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Cantargia AB
Nektar Therapeutics
Children's Oncology Group
Trans Tasman Radiation Oncology Group
Bristol-Myers Squibb
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Jewish General Hospital
Jewish General Hospital
Merck Sharp & Dohme LLC
Alliance for Clinical Trials in Oncology
University of California, San Francisco
Alliance for Clinical Trials in Oncology
Trans Tasman Radiation Oncology Group
New Mexico Cancer Research Alliance
Genentech, Inc.
Fred Hutchinson Cancer Center
University of Washington
Peking University Cancer Hospital & Institute
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Mayo Clinic
National Cancer Institute (NCI)
City of Hope Medical Center
Oncolytics Biotech
National Cancer Institute (NCI)
Children's Oncology Group
SCRI Development Innovations, LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fox Chase Cancer Center
National Cancer Institute (NCI)
Mayo Clinic